ANGO
Angiodynamics IncCompany with tickers: ANGO
CIK
1275187
CUSIP
03475V101
Shares Outstanding
41,318,915
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $233,567,000 | USD | 2026-02-28 | 10-Q | 2026-04-02 |
| Cost of Revenue | — | ||||
| Gross Profit | $128,119,000 | USD | 2026-02-28 | 10-Q | 2026-04-02 |
| Operating Expenses | $157,851,000 | USD | 2026-02-28 | 10-Q | 2026-04-02 |
| Research & Development | $21,269,000 | USD | 2026-02-28 | 10-Q | 2026-04-02 |
| Operating Income | $-29,732,000 | USD | 2026-02-28 | 10-Q | 2026-04-02 |
| Net Income | $-25,337,000 | USD | 2026-02-28 | 10-Q | 2026-04-02 |
| EPS (Basic) | $-0.61 | USD/shares | 2026-02-28 | 10-Q | 2026-04-02 |
| EPS (Diluted) | $-0.61 | USD/shares | 2026-02-28 | 10-Q | 2026-04-02 |